Skip to main content

Edesa Biotech, Inc.

EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001540159

No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.

13F holders, Q1 2021

Institutional positions in Edesa Biotech, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
16
No complete 13F data for Q4 2020
Shares held
143.4K
No complete 13F data for Q4 2020
Total value
$773.7K
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting EDSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 16 institutions
Q1 2021: 16 institutionsQ2 2021: 18 institutionsQ3 2021: 23 institutionsQ4 2021: 26 institutionsQ1 2022: 23 institutionsQ2 2022: 24 institutionsQ3 2022: 21 institutionsQ4 2022: 22 institutionsQ1 2023: 26 institutionsQ2 2023: 22 institutionsQ3 2023: 20 institutionsQ4 2023: 19 institutionsQ1 2024: 17 institutionsQ2 2024: 17 institutionsQ3 2024: 18 institutionsQ4 2024: 17 institutionsQ1 2025: 20 institutionsQ2 2025: 20 institutionsQ3 2025: 23 institutionsQ4 2025: 22 institutionsQ1 2026: 28 institutionsQ2 2026: 33 institutions
Value heldQ1 2021: $773.7K
Q1 2021: $773.7KQ2 2021: $1.37MQ3 2021: $2.85MQ4 2021: $2.03MQ1 2022: $5.51MQ2 2022: $2.26MQ3 2022: $494.2KQ4 2022: $3.53MQ1 2023: $2.05MQ2 2023: $1.63MQ3 2023: $1.26MQ4 2023: $507.1KQ1 2024: $450.9KQ2 2024: $645.1KQ3 2024: $718.2KQ4 2024: $350.1KQ1 2025: $6.89MQ2 2025: $4.28MQ3 2025: $7.10MQ4 2025: $4.34MQ1 2026: $13.8MQ2 2026: $30.0M
Institutions holding EDSA and their total value by quarter
QuarterHoldersValue
Q2 202633$30.0M
Q1 202628$13.8M
Q4 202522$4.34M
Q3 202523$7.10M
Q2 202520$4.28M
Q1 202520$6.89M
Q4 202417$350.1K
Q3 202418$718.2K
Q2 202417$645.1K
Q1 202417$450.9K
Q4 202319$507.1K
Q3 202320$1.26M
Q2 202322$1.63M
Q1 202326$2.05M
Q4 202222$3.53M
Q3 202221$494.2K
Q2 202224$2.26M
Q1 202223$5.51M
Q4 202126$2.03M
Q3 202123$2.85M
Q2 202118$1.37M
Q1 202116$773.7K

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Edesa Biotech, Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding EDSA in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc57,789$312.0K0.00%––
Geode Capital Management, LLC29,229$157.0K0.00%––
Stifel Financial Corp23,438$127.0K0.00%––
Virtu Financial LLC16,138$87.0K0.01%––
Northern Trust Corp15,349$83.0K0.00%––
Fifth Third Bancorp700$4.00K0.00%––
Royal Bank of Canada331$2.00K0.00%––
Advisor Group Holdings, Inc.104$1.00K0.00%––
Federation des caisses Desjardins du Quebec135$7290.00%––
American Portfolios Advisors2$110.00%––
Wells Fargo & Company47$00.00%––
Harbour Investments, Inc.28$00.00%––
Creative Financial Designs Inc23$00.00%––
Credit Agricole S A9$00.00%––
UBS Group AG33$00.00%––
AllSquare Wealth Management LLC10$00.00%––